Cite
HARVARD Citation
Bigal, M. et al. (n.d.). Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study. Lancet neurology. 14 (11), pp. 1091-1100. [Online].